BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 23300844)

  • 21. S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.
    Chuang JC; Warner SL; Vollmer D; Vankayalapati H; Redkar S; Bearss DJ; Qiu X; Yoo CB; Jones PA
    Mol Cancer Ther; 2010 May; 9(5):1443-50. PubMed ID: 20442312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
    Lemaire M; Momparler LF; Bernstein ML; Marquez VE; Momparler RL
    Anticancer Drugs; 2005 Mar; 16(3):301-8. PubMed ID: 15711182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
    Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
    Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
    Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
    Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
    Crea F; Giovannetti E; Cortesi F; Mey V; Nannizzi S; Gallegos Ruiz MI; Ricciardi S; Del Tacca M; Peters GJ; Danesi R
    Mol Cancer Ther; 2009 Jul; 8(7):1964-73. PubMed ID: 19531575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73.
    Liang W; Xia H; Li J; Chunhua Zhao R
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):108-15. PubMed ID: 22278203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
    Höglund A; Nilsson LM; Forshell LP; Maclean KH; Nilsson JA
    Blood; 2009 Apr; 113(18):4281-8. PubMed ID: 19179467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.
    Hollenbach PW; Nguyen AN; Brady H; Williams M; Ning Y; Richard N; Krushel L; Aukerman SL; Heise C; MacBeth KJ
    PLoS One; 2010 Feb; 5(2):e9001. PubMed ID: 20126405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.
    Snow GE; Kasper AC; Busch AM; Schwarz E; Ewings KE; Bee T; Spinella MJ; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2009 Oct; 9():383. PubMed ID: 19874621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA demethylation and invasive cancer: implications for therapeutics.
    Cheishvili D; Boureau L; Szyf M
    Br J Pharmacol; 2015 Jun; 172(11):2705-15. PubMed ID: 25134627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.
    Yagi S; Oda-Sato E; Uehara I; Asano Y; Nakajima W; Takeshita T; Tanaka N
    Cancer Invest; 2008 Aug; 26(7):680-8. PubMed ID: 18608210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
    Grande L; Bretones G; Rosa-Garrido M; Garrido-Martin EM; Hernandez T; Fraile S; Botella L; de Alava E; Vidal A; Garcia del Muro X; Villanueva A; Delgado MD; Fernandez-Luna JL
    J Biol Chem; 2012 Aug; 287(32):26495-505. PubMed ID: 22718761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
    Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
    Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis.
    Luo FY; Xiao S; Liu ZH; Zhang PF; Xiao ZQ; Tang CE
    Int J Clin Exp Pathol; 2015; 8(2):1658-65. PubMed ID: 25973051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.
    Mao P; Hever MP; Niemaszyk LM; Haghkerdar JM; Yanco EG; Desai D; Beyrouthy MJ; Kerley-Hamilton JS; Freemantle SJ; Spinella MJ
    J Biol Chem; 2011 Jun; 286(22):19381-91. PubMed ID: 21489989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
    Shen WJ; Dai DQ; Teng Y; Liu HB
    World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine.
    Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP
    Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.